Objective: Electrocardiography (ECG) may be a practical guiding tool for prognostic infarct sizing in ST elevation acute myocardial infarction (STEAMI). In this study, we sought to find a relation between the infarct size and the change in the QRS axis after thrombolytic therapy.
Introduction
Acute coronary syndromes (ACS) are the leading cause of death in the world [1] . There has been a measurable decrement in mortality and morbidity associated with ACS as a result of not only the recent achievements in pharmacological therapy but also the increased convenience and accessibility of medical help. However, ACS are still serious health problems that must be handled rapidly and effectively. ST elevation acute myocardial infarction (STEAMI) constitutes the most exclusive group amongst ACS. Improved survival due to widespread usage of thrombolytic therapy emphasizes the importance of restoration of blood flow. The main goal of therapy in the management of ACS is to focus on the improvement of the systems to provide restoration of blood flow to infarcting myocardium as soon as possible. The loss of jeopardized EAJM 2012; 44: myocardium and the related increment in mortality and morbidity when reperfusion is not achieved necessitates an early assessment of reperfusion and prognostic infarct sizing, which can be performed faster noninvasively. Among noninvasive methods, the most practical and guiding one is undoubtedly electrocardiography (ECG). To date, there are no data on the change in the QRS axis associated with ACS. In this study, we sought to find a relation between infarct size and the change in the QRS axis after thrombolytic therapy.
Materials and Methods
Patients who were hospitalized in the Ankara Ataturk Education and Research Hospital Coronary Care Unit with the diagnosis of ST elevation acute coronary syndrome between the 1 st of January, 2007, and the 1 st of January, 2009, were included in this study. Among these patients, those who received thrombolytic therapy were used in this study. Two ECGs, (one before thrombolytic therapy and one 90 minutes after thrombolytic therapy) were obtained. The mean QRS axes of these two ECGs were calculated by a formula 01 [2] :
This formula is generated and modified by geometrical summation of I, aVL and aVR in a hexa-axial plane. To estimate the QRS axis of patients with inferior MI, geometric summation of any derivations II, III or aVF were avoided because ST segment elevation may cause false changes in the mean QRS axis. If there were any reciprocal changes in the I or aVL leads, those patients were excluded from the study. Creatinine kinase MB (CKMB) was selected as a marker of infarct size. Patients who had branch blocks or an abnormal QRS axis in their ECGs, who developed branch blocks during thrombolytic therapy or who had renal failure were excluded.
Statistical analysis
Data analysis was performed in SPSS 15 for Windows, a statistical software application (SPSS Inc., Chicago, Illinois). Means±SD and proportions were used to summarize the characteristics of the study sample. After employing normality tests for continuous variables, the Wilcoxon Rank Summation test was used to evaluate the QRS axis difference between pre-and post-thrombolytic therapy because of the non-normally distributed character of the values. Because CK-MB and the degree of QRS axis change values are not normally distributed, Spearman correlation analysis was performed to evaluate the relation between CK-MB and the degree of QRS axis change in all patients and subgroups. Statistical significance was accepted at p<0.05. Simple regression analysis could not be performed because the data distribution did not meet the regression analysis criteria.
Results
The total number of patients included in this study was 85, and the mean age of the patients was 60.6±10.7 years (Table 1) . Among these patients, 35 (42.1%) were admitted with anterior myocardial infarction (MI), 15 (17.6%) were admitted with inferior MI, 16 (18.8%) were admitted with inferior+right MI, 8 (9.4%) were admitted with inferoposterolateral MI, 1 (1.2%) was admitted with lateral MI, 2 (2.4%) were admitted with posterolateral, and 1 (1.2%) was admitted with posterior MI. The mean left ventricular ejection fraction (LVEF) of the patients was 39.7%±10.1%. The change in the QRS axis before and after the thrombolytic therapy was significant (Z=-2, 33 p=0.02). In this particular study, we did not detect any significant correlation between infarct size and change in the QRS axis with respect to any MI localizations (p=0.80). However, regarding all of the MI localizations, CKMB and LVEF were found to be negatively correlated (r=-0.34 p=0.002) ( Table 2) . During subgroup analysis, there was good correlation between CKMB and change in the QRS axis (r=-0.52 p=0.049) only in the isolated inferior MI group. According to the scatter plot diagram, there may be a linear regression between the change in the QRS axis and infarct size in the isolated inferior MI patients (Figure 1 ). There was no significant correlation for other MI localizations (Table 3) .
Discussion
The beneficial effects of thrombolytic therapy on patient survival and LVEF set the primary goal of the therapy as restoration of blood flow as soon as possible in STEAMI. ST resolution after thrombolytic therapy shows epicardial, microvascular and tissue reperfusion [4] . However, because reperfusion cannot be achieved in all patients and in some patients silent reocclusion occurs, evaluation of reperfusion and prognostic infarct sizing with noninvasive methods are becoming more and more important [5] . The tool for this evaluation is, undoubtedly, ECG. ECG is a perfect tool for understanding reperfusion, but there is not enough data about the role of ECG in infarct sizing. Until now, the studies on jeopardized myocardium and infarct sizing have primarily used ST deviations and QRS scores [6] [7] [8] . In fact, biochemical markers, primarily CK-MB and troponin (Tn) T, have long been used for infarct sizing [9] [10] [11] [12] [13] [14] . In this context, for infarct sizing, markers like CK-MB and myoglobin are more appropriate than Tn T because of the higher rate of rising and falling serum levels. The correlation between the CK-MB release slope, infarct size and clinical outcomes has been known for many years [15] . Higher CK-MB values indicate more necrosis, wider infarcts and worse patient prognosis when compared to the slow and late completing nature of the release slope obtained by the usage of Tn T for infarct sizing.
In this particular study, the correlation between the infarct size and the change in the QRS axis of STEAMI patients is presented for the first time. The QRS axis in ECG represents the direction or angle of the ventricular depolarization. In fact, a normal QRS axis is neither sensitive nor specific, which means that a heart with a normal QRS axis may be normal or may have a serious pathology. Although there is no real consensus on the normal values of the QRS axis, in 2009, the ACC/AHA ECG guidelines updated the accepted values of a normal QRS axis to -30 and +90 degrees [16] . The QRS axis is calculated via the hexa-axial reference system. There are a number of different methods for calculating the QRS axis, but the geometric summation of projections of ventricular depolarization of the QRS axis on the hexa-axial plane is the most common. Computer software can also be used, but studies have shown that there is a high correlation between the QRS axes calculated by either inspection, computer or vector method [17] . Therefore, for practical purposes, we chose a formula derived from the original methodology prepared with the voltage values of I and aVF [2, 18] . Some believe that there may be a significant difference between patients, even in normal QRS axis ranges, and it would not be appropriate to use the QRS axis alone. Instead, as the QRS axis is made by all functioning myocardial cells, it can be foreseen that under life threatening conditions like ACS, which may endanger the contractile function or even the survival of cells, the QRS axis may change. Therefore, it is reasonable to use the change in the QRS axis as our measurement.
In STEAMIs, after cessation of the blood flow in the infarcted artery, a group of myocytes will not be functional, and a group of them will survive and continue to contract. Thrombolytic therapy has proven to be beneficial for survival and post-MI LVEF. In other words, it is effective to reduce the number of cells that lose function or the cells that have a high risk for losing function. Therefore, the change in the QRS axis immediately after the lytic therapy may be associated with the efficacy of thrombolytic therapy. It is possible that the more the cells are under risk, the more the cells could be salvaged. To put it another way, it may be thought that greater changes in the QRS axis are associated with smaller infarct sizes. Infarct size is determined primarily by the cells that lose function and become necrotic. In this study, we did not find a correlation between infarct size and the QRS axis change in any STEAMI patients. However, there was a good negative correlation between the QRS axis change and the infarct size in isolated inferior MIs. The significant negative correlation between LVEF and infarct size in anterior and right involved inferior MIs was an expected finding. To interpret these results, some points should be taken into consideration. The first is the concept of stunning. After an ischemic insult, contractile functions of ischemic myocardium are not restored immediately; they are restored long after the ischemia period [19] . If the ischemic insult is repeated, adapting to the changing environmental conditions, modulations occur in myocardial cells, and those cells cannot fulfill the contractile function even though they are alive. Under this condition, called "hibernation", if the flow is restored, then the time for myocardial cells to regain function may take months [20] . Due to this lengthy timeframe, in the very acute phase, reperfusion is achieved, and the life threatening condition is discarded. This means that the 90-minute period may not be adequate for the cells to regain function, which can lead to an underestimation of the actual number of cells that are salvaged by thrombolytic therapy and a reduced statistical significance. Secondly, the negative correlation between the QRS axis change and infarct size in isolated inferior MIs may reveal that the change in the QRS axis may become more prominent in small infarcts where LVEF is mildly affected. In addition, a mildly affected LVEF may be associated with less stunning, which supports the idea that, in large infarcts where LVEF is more affected, less significant statistical results may be observed because there are more stunned cells.
In conclusion, as ACS are complex and dynamic processes, the use of a combination of noninvasive methods should be encouraged to choose the candidates for rescue percutaneous coronary intervention, which will restore early reperfusion. Although the change in the QRS axis is rarely emphasized, it is a practical and promising tool for evaluating both the efficiency of the thrombolytic therapy and prognostic infarct sizing. 
Limitations
There are three main limitations to this study. The first limitation is the number of patients; to increase statistical power, more patients should have been included in the study. As with the previous limitation, MI subgroups may have been classified as anterior and inferior MI because more MI subgroups necessitate the inclusion of more patients in the study. The third limitation is that additional QRS axis change measurements should have been performed at the 24 th hour and on the 7 th day, in addition to the measurements made at the 90 th minute. There may not have been sufficient time to see if the stunned myocardial cells regained contractile function.
